Education
About Us
Working with TipRanks
Follow Us
Sight Sciences (SGHT)
NASDAQ:SGHT
SGHT Stock Chart & Stats
Day’s Range― - ―
52-Week Range$2.17 - $8.45
Previous CloseN/A
Volume59.09K
Average Volume (3M)250.99K
Market Cap
$122.83M
Enterprise Value$233.87M
Total Cash (Recent Filing)-$21.24M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta2.03
Next Earnings
May 01, 2025EPS Estimate
-0.28Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.03
Shares Outstanding50,754,616
10 Day Avg. Volume387,619
30 Day Avg. Volume250,990
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)1.54
Price to Cash Flow (P/CF)84.80
P/FCF Ratio20.80
Enterprise Value/Market Cap1.90
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit3.38
Enterprise Value/Ebitda-5.24
Forecast
1Y Price Target
$3.50Price Target Upside48.31% Upside
Rating ConsensusHold
Number of Analyst Covering8
---
Sight Sciences News
---
Bulls Say, Bears Say
Bulls Say
Cash PositionSight maintains a solid $120 million cash position, which enables flexibility for ongoing product launches, market access efforts, and further R&D investments.
Bears Say
Revenue Guidance2025 revenue guidance is below consensus due to the impact of LCDs on OMNI's volume outlook.
Sales PerformanceFourth-quarter sales of $19.1 million were in line with preannounced results, with total sales missing consensus by 6% prior to the prerelease.
---
Ownership Overview
29.81% Insiders
5.52% Mutual Funds
18.63% Other Institutional Investors
39.56% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
SGHT FAQ
What was Sight Sciences’s price range in the past 12 months?
Sight Sciences lowest stock price was $2.17 and its highest was $8.45 in the past 12 months.
What is Sight Sciences’s market cap?
Sight Sciences’s market cap is $122.83M.
When is Sight Sciences’s upcoming earnings report date?
Sight Sciences’s upcoming earnings report date is May 01, 2025 which is in 53 days.
How were Sight Sciences’s earnings last quarter?
Sight Sciences released its earnings results on Mar 05, 2025. The company reported -$0.23 earnings per share for the quarter, missing the consensus estimate of -$0.204 by -$0.026.
Is Sight Sciences overvalued?
According to Wall Street analysts Sight Sciences’s price is currently Undervalued.
Does Sight Sciences pay dividends?
Sight Sciences does not currently pay dividends.
What is Sight Sciences’s EPS estimate?
Sight Sciences’s EPS estimate is -0.28.
How many shares outstanding does Sight Sciences have?
Sight Sciences has 50,754,616 shares outstanding.
What happened to Sight Sciences’s price movement after its last earnings report?
Sight Sciences reported an EPS of -$0.23 in its last earnings report, missing expectations of -$0.204. Following the earnings report the stock price went up 2.893%.
Which hedge fund is a major shareholder of Sight Sciences?
Currently, no hedge funds are holding shares in SGHT
---
Sight Sciences Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$3.50 (48.31% Upside)
$3.50 (48.31% Upside)
Hedge Fund Trend
Decreased
By 11.3K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $213.4K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-45.51%
12-Months-Change
Fundamentals
Return on Equity
-49.59%
Trailing 12-Months
Asset Growth
-14.29%
Trailing 12-Months
Company Description
Sight Sciences
Sight Sciences Inc is a growth-stage medical device company transforming the two fastest growing segments in ophthalmology and optometry, glaucoma and dry eye disease. The company's product portfolio features the OMNI Surgical System, a dually-indicated device that facilitates the performance of both trabeculotomy and viscoelastic delivery. The company's non-surgical product portfolio consists of TearCare system which is commercially available for both ophthalmologists and optometrists.
---
SGHT Company Deck
---
SGHT Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call depicted a mixed outlook. While Sight Sciences achieved revenue growth and significant reductions in cash usage, challenges related to Medicare LCDs, a decline in TearCare revenue, and tariff impacts were notable. Clinical advancements and pipeline developments offer positive future potential. Overall, the sentiment reflects cautious optimism amid current challenges.Read More>---
SGHT Stock 12 Month Forecast
Average Price Target
$3.50
▲(48.31% Upside)
Technical Analysis
Best Analysts Covering SGHT
1 Year
1 Year Success Rate
2/11 ratings generated profit
1 Year Average Return
-2.07%
reiterated a buy rating 3 days ago
Copying Thomas Stephan's trades and holding each position for 1 Year would result in 18.18% of your transactions generating a profit, with an average return of -2.07% per trade.
---